Stock Events

Stock Events

Magenta Therapeutics 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-0.91
-0.85
-0.79
-0.73
Expected EPS
-0.7397368444
Actual EPS
N/A

Financials

-7,719.33%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.82MRevenue
-140.35MNet Income

Analyst Ratings

95.82Average Price Target
The highest estimate is 151.76.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3MT.STU. It's not an investment recommendation.
Bitcoin
2
BTC.CRYPTO
Meta Platforms
2
META
PDD
2
PDD
CorMedix
2
CRMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Show more...
CEO
Mr. Marino Garcia M.B.A.
Employees
92
Country
United States
ISIN
US55910K1088

Listings

XETRA
DE
87E.XETRA
STU
DE
87E.STU
MU
DE
3MT.MU
STU
DE
3MT.STU

0 Comments

Share your thoughts

FAQ

What is Magenta Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Magenta Therapeutics stocks are traded under the ticker 3MT.STU.
When is the next Magenta Therapeutics earnings date?▼
Magenta Therapeutics is going to release the next earnings report on August 06, 2026.
What were Magenta Therapeutics earnings last quarter?▼
3MT.STU earnings for the last quarter are -0.73 EUR per share, whereas the estimation was -0.91 EUR resulting in a +20.7% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Magenta Therapeutics revenue for the last year?▼
Magenta Therapeutics revenue for the last year amounts to 1.82M EUR.
What is Magenta Therapeutics net income for the last year?▼
3MT.STU net income for the last year is -140.35M EUR.
How many employees does Magenta Therapeutics have?▼
As of July 19, 2026, the company has 92 employees.
In which sector is Magenta Therapeutics located?▼
Magenta Therapeutics operates in the Health & Wellness sector.
When did Magenta Therapeutics complete a stock split?▼
Magenta Therapeutics has not had any recent stock splits.
Where is Magenta Therapeutics headquartered?▼
Magenta Therapeutics is headquartered in New York, United States.